This compound is a bioconjugation reagent featuring a DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) core and a maleimide group. Its design enables site-specific attachment to targeting molecules, making it a tool for constructing targeted imaging agents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing DOTA-maleimido?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-Chloro-4-(hydroxymethyl)pyridine
research compound
2-(2-Naphthalenyl)pyrrolidine
research compound
2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazole
research compound
2-NP-AHD-13C3
research compound
Tri-tert-butyl 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
pharmaceutical intermediate
2-[4,7-bis(carboxymethyl)-10-[2-[2-(2,5-dioxopyrrol-1-yl)ethylamino]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
AUTDIWAXETZSGJ-UHFFFAOYSA-N
C1CN(CCN(CCN(CCN1CC(=O)NCCN2C(=O)C=CC2=O)CC(=O)O)CC(=O)O)CC(=O)O
Sourcing DOTA-maleimido?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.